- Investing Ideas
- /
- Consumer Retailing Healthcare Sector
Consumer Retailing Healthcare Sector
Results
2305
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2305 companies
CollPlant Biotechnologies
Market Cap: US$23.0m
A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
CLGN
US$1.93
7D
11.6%
1Y
-66.5%
Enlivex Therapeutics
Market Cap: US$22.9m
Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.
ENLV
US$0.97
7D
-2.5%
1Y
-30.4%
Avicanna
Market Cap: CA$31.3m
A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide.
AVCN
CA$0.27
7D
-7.0%
1Y
3.9%
ImmunoPrecise Antibodies
Market Cap: US$22.4m
Operates as a techbio company.
IPA
US$0.56
7D
12.6%
1Y
-49.8%
CurveBeam AI
Market Cap: AU$34.3m
Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America.
CVB
AU$0.088
7D
-2.2%
1Y
-49.7%
Basel Medical Group
Market Cap: US$22.2m
Provides healthcare services in Singapore.
BMGL
US$1.37
7D
-42.2%
1Y
n/a
Nova Eye Medical
Market Cap: AU$34.1m
Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
EYE
AU$0.12
7D
-4.0%
1Y
-55.6%
Clene
Market Cap: US$22.0m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$2.37
7D
-7.8%
1Y
-66.2%
Tempest Therapeutics
Market Cap: US$22.0m
A clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
TPST
US$6.23
7D
-9.1%
1Y
-85.2%
LakeShore Biopharma
Market Cap: US$21.8m
A biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer.
LSB
US$1.10
7D
2.8%
1Y
-89.2%
Passage Bio
Market Cap: US$21.7m
A genetic medicines company, develops gene therapies for central nervous system diseases.
PASG
US$0.37
7D
22.5%
1Y
-67.3%
Lisata Therapeutics
Market Cap: US$21.6m
A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
LSTA
US$2.70
7D
2.7%
1Y
-8.8%
1CM
Market Cap: CA$29.4m
Operates as a multi-jurisdictional cannabis company in Canada.
EPIC
CA$0.25
7D
0%
1Y
-72.5%
Sol-Gel Technologies
Market Cap: US$21.4m
Together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel.
SLGL
US$7.59
7D
1.6%
1Y
-5.1%
Arecor Therapeutics
Market Cap: UK£15.7m
A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.
AREC
UK£0.41
7D
1.2%
1Y
-73.8%
Cambridge Cognition Holdings
Market Cap: UK£15.6m
A neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally.
COG
UK£0.38
7D
1.4%
1Y
-16.7%
Apimeds Pharmaceuticals US
Market Cap: US$21.1m
Operates as a clinical stage biopharmaceutical company in the United States.
APUS
US$1.81
7D
6.5%
1Y
n/a
Kenilworth Systems
Market Cap: US$20.9m
Provides medical travel consulting and referral services.
KENS
US$0.25
7D
25.0%
1Y
-35.9%
Finch Therapeutics Group
Market Cap: US$20.9m
A clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
FNCH
US$13.00
7D
-2.0%
1Y
622.2%
Curis
Market Cap: US$20.8m
A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
CRIS
US$2.00
7D
-1.5%
1Y
-82.1%
Nexalin Technology
Market Cap: US$20.8m
A medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China.
NXL
US$1.23
7D
-3.1%
1Y
21.8%
Vext Science
Market Cap: CA$28.5m
Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.
VEXT
CA$0.12
7D
9.1%
1Y
-50.0%
MIRA Pharmaceuticals
Market Cap: US$20.7m
Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
MIRA
US$1.22
7D
-15.9%
1Y
37.9%
Little Green Pharma
Market Cap: AU$31.9m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.10
7D
-4.5%
1Y
-16.0%
Longeveron
Market Cap: US$20.5m
A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
LGVN
US$1.35
7D
-4.9%
1Y
22.7%
Rubicon Organics
Market Cap: CA$28.1m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.40
7D
-8.0%
1Y
8.1%
Relmada Therapeutics
Market Cap: US$20.4m
Operates as a clinical-stage biotechnology company in the United States.
RLMD
US$0.64
7D
38.7%
1Y
-79.0%
Ovid Therapeutics
Market Cap: US$20.4m
A biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States.
OVID
US$0.29
7D
-5.8%
1Y
-90.5%
HOOKIPA Pharma
Market Cap: US$20.3m
A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.
HOOK
US$1.51
7D
-3.2%
1Y
-81.1%
PAVmed
Market Cap: US$20.3m
Engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
PAVM
US$0.65
7D
-0.3%
1Y
-62.6%
Q32 Bio
Market Cap: US$20.1m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$1.62
7D
-8.5%
1Y
-93.8%
Eastwood Bio-Medical Canada
Market Cap: CA$27.6m
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.
EBM
CA$0.40
7D
0%
1Y
-33.3%
Voyageur Pharmaceuticals
Market Cap: CA$27.3m
Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.
VM
CA$0.17
7D
6.3%
1Y
240.0%
Woodbrook Group Holdings
Market Cap: US$19.9m
Provides investment and strategic planning advisory services.
WDBG
US$0.06
7D
0%
1Y
19.8%
Lipocine
Market Cap: US$19.7m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
LPCN
US$3.58
7D
-10.3%
1Y
-48.0%
ABVC BioPharma
Market Cap: US$19.7m
A clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.
ABVC
US$1.15
7D
-22.3%
1Y
23.0%